Mehraeen E, Dadras O, Afsahi AM, Karimi A, Pour MM, Mirzapour P, et al. Vaccines for COVID-19: A Systematic Review of Feasibility and Effectiveness. Infectious disorders drug targets. 2022;22(2):e230921196758.

SeyedAlinaghi S, Karimi A, Barzegary A, Mojdeganlou H, Vahedi F, Mirghaderi SP, et al. COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review. 2022;27(1):195.

Collier A-rY, Yu J, McMahan K, Liu J, Chandrashekar A, Maron JS, et al. Differential kinetics of immune responses elicited by Covid-19 vaccines. New England Journal of Medicine. 2021;385(21):2010-2.

Shreyas Madhav A, Rajaraman R, Harini S, Kiliroor CC. Application of artificial intelligence to enhance collection of E-waste: A potential solution for household WEEE collection and segregation in India. Waste Management & Research. 2022;40(7):1047-53.

Dong Y, Dai T, Wei Y, Zhang L, Zheng M, Zhou F. A systematic review of SARS-CoV-2 vaccine candidates. Signal transduction and targeted therapy. 2020;5(1):237.

Pormohammad A, Zarei M, Ghorbani S, Mohammadi M, Razizadeh MH, Turner DL, et al. Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials. Vaccines. 2021;9(5):467.

Larijani MS, Ashrafian F, Amiri FB, Banifazl M, Bavand A, Karami A, et al. Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran. Microbial pathogenesis. 2022;169:105618.

Sharif N, Alzahrani KJ, Ahmed SN, Dey SK. Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis. Frontiers in immunology. 2021;12:4149.

Mehraeen E, Oliaei S, SeyedAlinaghi S, Karimi A, Mirzapour P, Afsahi AM, et al. COVID-19 in Pediatrics: A Systematic Review of Current Knowledge and Practice. Infectious disorders drug targets. 2022;22(5):47-57.

Garcia-Beltran WF, Denis KJS, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, et al. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell. 2022;185(3):457-66. e4.

Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Shcheblyakov DV, Dzharullaeva AS, et al. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. The Lancet. 2020;396(10255):887-97.

Zhu F-C, Guan X-H, Li Y-H, Huang J-Y, Jiang T, Hou L-H, et al. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet. 2020;396(10249):479-88.

Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet. 2020;396(10267):1979-93.

BRISTOL Uo. ROBIS: University of BRISTOL; 2023 [Available from: https://www.bristol.ac.uk/population-health-sciences/projects/robis/.

Bhurwal A, Mutneja H, Bansal V, Goel A, Arora S, Attar B, et al. Effectiveness and safety of SARS‐CoV‐2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta‐analysis and meta‐regression. Alimentary Pharmacology & Therapeutics. 2022;55(10):1244-64.

Teh JS, Coussement J, Neoh ZC, Spelman T, Lazarakis S, Slavin MA, et al. Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis. Blood Advances. 2022;6(7):2014-34.

Shear S, Shams K, Weisberg J, Hamidi N, Scott S. COVID-19 vaccination safety profiles in patients with solid tumour cancers: a systematic review. Clinical Oncology. 2023.

Tan SYS, Yee AM, Sim JJL, Lim CC. COVID-19 vaccination in systemic lupus erythematosus: a systematic review of its effectiveness, immunogenicity, flares and acceptance. Rheumatology. 2023;62(5):1757-72.

Tang K-T, Hsu B-C, Chen D-Y. Immunogenicity, effectiveness, and safety of COVID-19 vaccines in rheumatic patients: an updated systematic review and meta-analysis. Biomedicines. 2022;10(4):834.

Chirasuthat S, Ratanapokasatit Y, Thadanipon K, Chanprapaph K. Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines among Patients with Immune-Mediated Dermatological Diseases: A Systematic Review and Meta-analysis. Acta Dermato-Venereologica. 2024;104.

Ning F, Cao X-q, Wang Q-q, Li Z-y, Ruan Z, Chang T. Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis. Heliyon. 2024;10(1).

Li K, Xia Y, Ye H, Sun X, Shi B, Wu J. Effectiveness and safety of immune response to SARS‑CoV‑2 vaccine in patients with chronic kidney disease and dialysis: A systematic review and meta‑analysis. Biomedical Reports. 2024;20(5):1-10.

Efros O, Anteby R, Halfon M, Meisel E, Klang E, Soffer S. Efficacy and safety of third dose of the COVID-19 vaccine among solid organ transplant recipients: a systemic review and meta-analysis. Vaccines. 2022;10(1):95.

Rubin M, Suelzer E, Ulschmid C, Thapa B, Szabo A, Abid MB. Efficacy of sars-cov-2 vaccine doses in allogeneic hemopoietic stem cell recipients: A systematic review and meta-analysis. Asian Pacific Journal of Cancer Prevention: APJCP. 2024;25(2):393.

Lv M, Luo X, Shen Q, Lei R, Liu X, Liu E, et al. Safety, immunogenicity, and efficacy of COVID-19 vaccines in children and adolescents: A systematic review. Vaccines. 2021;9(10):1102.

Sadeghi S, Kalantari Y, Shokri S, Fallahpour M, Nafissi N, Goodarzi A, et al. Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 - 21 years old: A Systematic Review and Meta-analysis. J Clin Virol. 2022;153:105196.

Yang XH, Bao WJ, Zhang H, Fu SK, Jin HM. The Efficacy of SARS-CoV-2 Vaccination in the Elderly: A Systemic Review and Meta-analysis. Journal of General Internal Medicine. 2023:1-9.

Fernández-García S, del Campo-Albendea L, Sambamoorthi D, Sheikh J, Lau K, Osei-Lah N, et al. Effectiveness and safety of COVID-19 vaccines on maternal and perinatal outcomes: a systematic review and meta-analysis. BMJ Global Health. 2024;9(4):e014247.

Januszek SM, Faryniak-Zuzak A, Barnaś E, Łoziński T, Góra T, Siwiec N, et al. The approach of pregnant women to vaccination based on a COVID-19 systematic review. Medicina. 2021;57(9):977.

Rawal S, Tackett RL, Stone RH, Young HN. COVID-19 vaccination among pregnant people in the United States: a systematic review. American journal of obstetrics & gynecology MFM. 2022;4(4):100616.

Santimano AJ, Al-Zoubi RM, Al-Qudimat AR, Al Darwish MB, Ojha LK, Rejeb MA, et al. Efficacy and Clinical Outcomes of mRNA COVID-19 Vaccine in Pregnancy: A Systematic Review and Meta-Analysis. Intervirology. 2024;67(1):40-54.

Tamb BMMAR, Chana KW, Chi IFNHS, Chana WTTM, Yapa DY-H. Immunogenicity and Safety of the Three-Dose COVID-19 Vaccine Regimen in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis. mortality. 2024;1:4.

Glhoom S, Fergany A, El-Araby D, Abdelkhalek AA, Gomaa A, Zayed EO, et al. The efficacy of tixagevimab/cilgavimab (Evusheld) in prophylaxis and treatment of COVID-19 in immunocompromised patients: a systematic review and meta-analysis. European journal of medical research. 2024;29(1):27.

Fu C, Lin N, Zhu J, Ye Q. Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review. Vaccines (Basel). 2023;11(5).

Sandoval C, Guerrero D, Muñoz J, Godoy K, Souza-Mello V, Farías J. Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: A systematic review. Expert Review of Vaccines. 2023;22(1):35-53.

Dadras O, Mehraeen E, Karimi A, Tantuoyir MM, Afzalian A, Nazarian N, et al. Safety and adverse events related to inactivated COVID-19 vaccines and Novavax; a systematic review. Archives of Academic Emergency Medicine. 2022;10(1).

Cheng M-q, Weng Z-Y, Li R, Song G. Efficacy of adjuvant-associated COVID-19 vaccines against SARS-CoV-2 variants of concern in randomized controlled trials: A systematic review and meta-analysis. Medicine. 2024;103(7):e35201.

Primieri C, Bietta C, Giacchetta I, Chiavarini M, De Waure C. Determinants of COVID-19 vaccination acceptance or hesitancy in Italy: an overview of the current evidence. Annali dell'Istituto Superiore di Sanita. 2023;59(1):10-25.

Kacimi SEO, Klouche-Djedid SN, Riffi O, Belaouni HA, Yasmin F, Essar MY, et al. Determinants of COVID-19 Vaccine Engagement in Algeria: A Population-Based Study With Systematic Review of Studies From Arab Countries of the MENA Region. Frontiers in Public Health. 2022;10:843449.

Hadi YB, Thakkar S, Shah-Khan SM, Hutson W, Sarwari A, Singh S. COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States. Gastroenterology. 2021;161(4):1336-9.e3.

Weaver KN, Zhang X, Dai X, Watkins R, Adler J, Dubinsky MC, et al. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Inflamm Bowel Dis. 2022;28(10):1497-505.

Ben-Tov A, Banon T, Chodick G, Kariv R, Assa A, Gazit S. BNT162b2 Messenger RNA COVID-19 Vaccine Effectiveness in Patients With Inflammatory Bowel Disease: Preliminary Real-World Data During Mass Vaccination Campaign. Gastroenterology. 2021;161(5):1715-7.e1.

Kappelman MD, Weaver KN, Zhang X, Dai X, Watkins R, Adler J, et al. Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases. Am J Gastroenterol. 2022;117(3):462-9.

Hall VG, Solera JT, Al-Alahmadi G, Marinelli T, Cardinal H, Poirier C, et al. Severity of COVID-19 among solid organ transplant recipients in Canada, 2020-2021: a prospective, multicentre cohort study. Cmaj. 2022;194(33):E1155-e63.

Balcells ME, Le Corre N, Durán J, Ceballos ME, Vizcaya C, Mondaca S, et al. Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile. Clin Infect Dis. 2022;75(1):e594-e602.

Naylor KL, Kim SJ, Smith G, McArthur E, Kwong JC, Dixon SN, et al. Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada. Am J Transplant. 2022;22(9):2228-36.

Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202-21.

Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N Engl J Med. 2021;385(7):585-94.

Sheikh A, McMenamin J, Taylor B, Robertson C. SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021;397(10293):2461-2.

Li XN, Huang Y, Wang W, Jing QL, Zhang CH, Qin PZ, et al. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study. Emerg Microbes Infect. 2021;10(1):1751-9.

Pellini R, Venuti A, Pimpinelli F, Abril E, Blandino G, Campo F, et al. Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine. EClinicalMedicine. 2021;36:100928.

Kouhpayeh H, Ansari H. Adverse events following COVID-19 vaccination: A systematic review and meta-analysis. Int Immunopharmacol. 2022;109:108906.

Castells MC, Phillips EJ. Maintaining Safety with SARS-CoV-2 Vaccines. N Engl J Med. 2021;384(7):643-9.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-94.

Gwak E, Kim T, Shin JY, Choi NK, Han S, Lee JY, et al. Effectiveness and Safety of COVID-19 Vaccination During Preconceptional and Preclinical Pregnancy Period: A National Population Study. J Korean Med Sci. 2023;38(41):e314.

Ma Y, Shan Z, Gu Y, Huang Y. Safety and efficacy of inactivated COVID-19 vaccines in women vaccinated during the first trimester of pregnancy. Int J Infect Dis. 2023;130:196-202.

Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, et al. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. N Engl J Med. 2022;386(1):35-46.

Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021;21(1):39-51.

Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(12):1645-53.

Bono SA, Faria de Moura Villela E, Siau CS, Chen WS, Pengpid S, Hasan MT, et al. Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries. Vaccines (Basel). 2021;9(5).

Azanaw J, Endalew M, Zenbaba D, Abera E, Chattu VK. COVID-19 vaccine acceptance and associated factors in 13 African countries: A systematic review and meta-analysis. Front Public Health. 2022;10:1001423.

Fan Y-J, Chan K-H, Hung IF-N. Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of different vaccines at phase 3. Vaccines. 2021;9(9):989.

Harada R, Oyama T, Fujimoto K, Shimizu T, Ozawa M, Amar JS, et al. Trash detection algorithm suitable for mobile robots using improved yolo. Journal of Advanced Computational Intelligence and Intelligent Informatics. 2023;27(4):622-31.

Rinaldi I, Pratama S, Wiyono L, Tandaju JR, Wardhana IL, Winston K. Efficacy and safety profile of COVID-19 mRNA vaccine in patients with hematological malignancies: Systematic review and meta-analysis. Frontiers in Oncology. 2022;12:951215.

Barshan AD, Matsumoto-Takahashi ELA. Efficacy of COVID-19 Vaccines in Patients with Hematological Malignancy Compared to Healthy Controls: A Systematic Review and Meta-analysis. JMA journal. 2024;7(2):153-71.

Choi S-H, Yu S-Y, Kim J, Choi M, Choi YY, Choi JH, et al. Efficacy and Safety of COVID-19 Vaccines in Adolescents: Systematic Review of Randomized Controlled Studies and Observational Studies. Pediatric Infection & Vaccine. 2024;31(1):12-24.

Song G, Li R, Cheng Mq. Safety, immunogenicity, and protective effective of inhaled COVID‐19 vaccines: A systematic review and meta‐analysis. Journal of Medical Virology. 2024;96(4):e29625.